This inventor holds 1 USPTO granted patent. Top assignee: Elan Pharma International Limited. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Duran T Anstine: Innovator in Cell Death Inhibition
Introduction
Duran T Anstine is a notable inventor based in Nampa, ID (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of cell death inhibition. His innovative work has the potential to impact various medical conditions associated with cell death.
Latest Patents
Duran T Anstine holds 1 patent for his invention titled "Bis-benzimidazole compounds and analogs thereof for inhibiting cell death." This patent describes compounds, pharmaceutical compositions, and methods that are effective in inhibiting cell death, especially apoptotic cell death. The compositions can be utilized for the prevention and treatment of injuries related to cell death, including ischemia resulting from conditions such as stroke or myocardial infarction, trauma, neurodegeneration, and inflammation.
Career Highlights
Duran T Anstine is currently associated with Elan Pharma International Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for patients facing serious health challenges.
Collaborations
Throughout his career, Duran has collaborated with esteemed colleagues, including Catherine M Bitler and Paul L Wood. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Duran T Anstine's contributions to the field of pharmaceuticals, particularly in inhibiting cell death, highlight his role as an influential inventor. His work not only showcases his innovative spirit but also holds promise for future medical advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile